LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.83 | 770.25 | 9646 | 10078 | 0.9571 | 0.9765 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 67.83 | 770.25 | 10716 | 10078 | 1.0633 | 1.0333 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.05 | 770.25 | 10098 | 10413 | 0.9697 | 0.9837 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 70.05 | 770.25 | 11094 | 10413 | 1.0653 | 1.0340 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 72.27 | 770.25 | 10493 | 10730 | 0.9778 | 0.9882 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 72.27 | 770.25 | 11448 | 10730 | 1.0668 | 1.0343 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.50 | 770.25 | 10901 | 10991 | 0.9918 | 0.9957 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 74.50 | 770.25 | 11790 | 10991 | 1.0726 | 1.0369 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 76.75 | 770.25 | 11261 | 11262 | 0.9998 | 0.9999 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 76.75 | 770.25 | 11997 | 11262 | 1.0652 | 1.0329 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 78.98 | 770.25 | 11646 | 11518 | 1.0111 | 1.0057 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 78.98 | 770.25 | 12495 | 11518 | 1.0848 | 1.0422 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 81.20 | 770.25 | 12052 | 11766 | 1.0243 | 1.0122 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 81.20 | 770.25 | 12857 | 11766 | 1.0927 | 1.0456 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 83.42 | 770.25 | 12418 | 12031 | 1.0321 | 1.0160 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 83.42 | 770.25 | 13171 | 12031 | 1.0947 | 1.0461 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 85.64 | 770.25 | 12706 | 12287 | 1.0341 | 1.0168 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 85.64 | 770.25 | 13626 | 12287 | 1.1089 | 1.0524 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 87.86 | 770.25 | 13364 | 12543 | 1.0654 | 1.0317 | MN20160304_L02 | E16 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00033333 | 87.86 | 770.25 | 14003 | 12543 | 1.1164 | 1.0554 | MN20160304_L02 | E21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 3.21 | 770.25 | 919 | 904 | 1.0159 | 1.1406 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 3.21 | 770.25 | 856 | 904 | 0.9463 | 0.5762 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 5.44 | 770.25 | 1003 | 1012 | 0.9904 | 0.9516 | MN20160304_L02 | C19 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 5.44 | 770.25 | 954 | 1012 | 0.9420 | 0.7191 | MN20160304_L02 | D18 |
| MCF 10A-H2B-mCherry | Trametinib | 0.00066667 | 7.66 | 770.25 | 1064 | 1090 | 0.9762 | 0.9059 | MN20160304_L02 | C19 |